pentobarbital will increase toxicity of methoxyflurane by escalating metabolism. Contraindicated. Elevated metabolism of methoxyflurane to nephrotoxic compounds.

pentobarbital will decrease the extent or effect of tamoxifen by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will lower the extent or influence of buprenorphine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital will decrease the level or impact of cilostazol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.

Warning with use for the duration of surgeries or procedures in small children youthful than 3 yr or in Expecting Girls in the course of their third trimester

pentobarbital will minimize the extent or result of alfentanil by affecting hepatic/intestinal check here enzyme CYP3A4 metabolism. Slight/Significance Mysterious.

pentobarbital will minimize the extent or influence of pimozide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.

pentobarbital will lessen the level or influence of midazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

pentobarbital will lower the extent or influence of repaglinide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

pentobarbital will lower the extent or impact of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the extent or outcome of ramelteon by influencing hepatic enzyme CYP2C9/ten metabolism. Insignificant/Importance Unfamiliar.

pentobarbital will reduce the level or outcome of pantoprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

pentobarbital will lower the level or result of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

Keep an eye on Intently (1)pentobarbital will reduce the extent or outcome of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Use of alternative treatment options is strongly advisable when linagliptin should be to be administered having a CYP3A4 inducer